BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 22749331)

  • 1. The neurobiology of sirtuins and their role in neurodegeneration.
    Donmez G
    Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    Huber K; Superti-Furga G
    Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Aljada A; Dong L; Mousa SA
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1.
    Kelly G
    Altern Med Rev; 2010 Sep; 15(3):245-63. PubMed ID: 21155626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven sirtuins for seven deadly diseases of aging.
    Morris BJ
    Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2.
    Kelly GS
    Altern Med Rev; 2010 Dec; 15(4):313-28. PubMed ID: 21194247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuins as possible targets in neurodegenerative diseases.
    Donmez G
    Curr Drug Targets; 2013 Jun; 14(6):644-7. PubMed ID: 23410123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of activators and inhibitors of sirtuins.
    Balcerczyk A; Pirola L
    Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic role of sirtuins in neurodegenerative disease.
    Outeiro TF; Marques O; Kazantsev A
    Biochim Biophys Acta; 2008 Jun; 1782(6):363-9. PubMed ID: 18373985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New assays and approaches for discovery and design of Sirtuin modulators.
    Schutkowski M; Fischer F; Roessler C; Steegborn C
    Expert Opin Drug Discov; 2014 Feb; 9(2):183-99. PubMed ID: 24382304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases.
    Knutson MD; Leeuwenburgh C
    Nutr Rev; 2008 Oct; 66(10):591-6. PubMed ID: 18826454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
    Albani D; Polito L; Forloni G
    J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sirtuins--modulation of their activity as a novel therapeutic target].
    Kucińska M; Piotrowska H; Murias M
    Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin activators.
    Alcaín FJ; Villalba JM
    Expert Opin Ther Pat; 2009 Apr; 19(4):403-14. PubMed ID: 19441923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Sirtuins and Molecular Mechanisms of Aging.
    van de Ven RAH; Santos D; Haigis MC
    Trends Mol Med; 2017 Apr; 23(4):320-331. PubMed ID: 28285806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal protection by sirtuins in Alzheimer's disease.
    Anekonda TS; Reddy PH
    J Neurochem; 2006 Jan; 96(2):305-13. PubMed ID: 16219030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin3 in Neurological Disorders.
    Sherin F; Gomathy S; Antony S
    Curr Drug Res Rev; 2021; 13(2):140-147. PubMed ID: 33290206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichotomous Sirtuins: Implications for Drug Discovery in Neurodegenerative and Cardiometabolic Diseases.
    Gomes P; Leal H; Mendes AF; Reis F; Cavadas C
    Trends Pharmacol Sci; 2019 Dec; 40(12):1021-1039. PubMed ID: 31704173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin deacetylases in neurodegenerative diseases of aging.
    Herskovits AZ; Guarente L
    Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.